Indeed, a stable GLP‐1‐17β‐estradiol conjugate has demonstrated superior efficacy over GLP‐1 single hormone in treating metabolic syndrome in both male and female mice [188]. This evidence concerns the gene GLP1R and metabolic syndrome.